Verheijen JH - Search Results

1

Oral matrix metalloproteinase inhibition and arterial remodeling after balloon dilation: an intravascular ultrasound study in the pig.

Sierevogel MJ, Pasterkamp G, Velema E, de Jaegere PP, de Smet BJ, Verheijen JH, de Kleijn DP, Borst C. Sierevogel MJ, et al. Among authors: verheijen jh. Circulation. 2001 Jan 16;103(2):302-7. doi: 10.1161/01.cir.103.2.302. Circulation. 2001. PMID: 11208693

2

Metalloproteinase inhibition reduces constrictive arterial remodeling after balloon angioplasty: a study in the atherosclerotic Yucatan micropig.

de Smet BJ, de Kleijn D, Hanemaaijer R, Verheijen JH, Robertus L, van Der Helm YJ, Borst C, Post MJ. de Smet BJ, et al. Among authors: verheijen jh. Circulation. 2000 Jun 27;101(25):2962-7. doi: 10.1161/01.cir.101.25.2962. Circulation. 2000. PMID: 10869270

3

Matrix metalloproteinase 2 is associated with stable and matrix metalloproteinases 8 and 9 with vulnerable carotid atherosclerotic lesions: a study in human endarterectomy specimen pointing to a role for different extracellular matrix metalloproteinase inducer glycosylation forms.

Sluijter JP, Pulskens WP, Schoneveld AH, Velema E, Strijder CF, Moll F, de Vries JP, Verheijen J, Hanemaaijer R, de Kleijn DP, Pasterkamp G. Sluijter JP, et al. Stroke. 2006 Jan;37(1):235-9. doi: 10.1161/01.STR.0000196986.50059.e0. Epub 2005 Dec 8. Stroke. 2006. PMID: 16339461

4

Age-related changes in plaque composition: a study in patients suffering from carotid artery stenosis.

van Oostrom O, Velema E, Schoneveld AH, de Vries JP, de Bruin P, Seldenrijk CA, de Kleijn DP, Busser E, Moll FL, Verheijen JH, Virmani R, Pasterkamp G. van Oostrom O, et al. Among authors: verheijen jh. Cardiovasc Pathol. 2005 May-Jun;14(3):126-34. doi: 10.1016/j.carpath.2005.03.002. Cardiovasc Pathol. 2005. PMID: 15914297

5

Statin treatment is not associated with consistent alterations in inflammatory status of carotid atherosclerotic plaques: a retrospective study in 378 patients undergoing carotid endarterectomy.

Verhoeven BA, Moll FL, Koekkoek JA, van der Wal AC, de Kleijn DP, de Vries JP, Verheijen JH, Velema E, Busser E, Schoneveld A, Virmani R, Pasterkamp G. Verhoeven BA, et al. Among authors: verheijen jh. Stroke. 2006 Aug;37(8):2054-60. doi: 10.1161/01.STR.0000231685.82795.e5. Epub 2006 Jun 29. Stroke. 2006. PMID: 16809559

6

Collagenase matrix metalloproteinase-8 expressed in atherosclerotic carotid plaques is associated with systemic cardiovascular outcome.

Peeters W, Moll FL, Vink A, van der Spek PJ, de Kleijn DP, de Vries JP, Verheijen JH, Newby AC, Pasterkamp G. Peeters W, et al. Among authors: verheijen jh. Eur Heart J. 2011 Sep;32(18):2314-25. doi: 10.1093/eurheartj/ehq517. Epub 2011 Feb 2. Eur Heart J. 2011. PMID: 21289041

7

Adenoviral expression of a urokinase receptor-targeted protease inhibitor inhibits neointima formation in murine and human blood vessels.

Quax PH, Lamfers ML, Lardenoye JH, Grimbergen JM, de Vries MR, Slomp J, de Ruiter MC, Kockx MM, Verheijen JH, van Hinsbergh VW. Quax PH, et al. Among authors: verheijen jh. Circulation. 2001 Jan 30;103(4):562-9. doi: 10.1161/01.cir.103.4.562. Circulation. 2001. PMID: 11157723

8

Assessment of the clinical significance of serum matrix metalloproteinases MMP-2 and MMP-9 in patients with various chronic liver diseases and hepatocellular carcinoma.

Kuyvenhoven JP, van Hoek B, Blom E, van Duijn W, Hanemaaijer R, Verheijen JH, Lamers CB, Verspaget HW. Kuyvenhoven JP, et al. Among authors: verheijen jh. Thromb Haemost. 2003 Apr;89(4):718-25. Thromb Haemost. 2003. PMID: 12669127

9

Urinary matrix metalloproteinase-8 and -9 activities in type 2 diabetic subjects: A marker of incipient diabetic nephropathy?

van der Zijl NJ, Hanemaaijer R, Tushuizen ME, Schindhelm RK, Boerop J, Rustemeijer C, Bilo HJ, Verheijen JH, Diamant M. van der Zijl NJ, et al. Among authors: verheijen jh. Clin Biochem. 2010 May;43(7-8):635-9. doi: 10.1016/j.clinbiochem.2010.02.006. Epub 2010 Feb 23. Clin Biochem. 2010. PMID: 20184870

10

Eradication of Helicobacter pylori infection favourably affects altered gastric mucosal MMP-9 levels.

Kubben FJ, Sier CF, Schram MT, Witte AM, Veenendaal RA, van Duijn W, Verheijen JH, Hanemaaijer R, Lamers CB, Verspaget HW. Kubben FJ, et al. Among authors: verheijen jh. Helicobacter. 2007 Oct;12(5):498-504. doi: 10.1111/j.1523-5378.2007.00527.x. Helicobacter. 2007. PMID: 17760717 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

120 results

Search Page

Filters